Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02337556 · ClinicalTrials.gov registry record · NA
The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 106
- Enrollment target
NCT02337556 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 106 participants.
The verdict
NCT02337556, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 106 participants
- Enrollment target
Study Summary
To compare the nutritional effect on blood glucose of two commercially available enteral diets in overweight or obese patients in the Intensive Care Unit.
Interventions
- OTHER Peptamen Bariatric
- OTHER Replete
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 106 participants |
| Start Date | 2014-11 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02337556
The ClinicalTrials.gov registry entry for NCT02337556 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Peptamen Bariatric is the first listed.
NCT02337556 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02337556 about?
NCT02337556 is a clinical study titled "The DIVINE Study: DIetary Management of Glucose VarIability iN thE ICU". To compare the nutritional effect on blood glucose of two commercially available enteral diets in overweight or obese patients in the Intensive Care Unit.
What is the current status of trial NCT02337556?
This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2014-11. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02337556?
The interventions under investigation include: Peptamen Bariatric (OTHER), Replete (OTHER).
Who is sponsoring clinical trial NCT02337556?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.